EBITDA Summary of Sunder Biomedical Tech. Co., Ltd.

Sunder Biomedical Tech. Co., Ltd.'s latest annual EBITDA in 2023 was 76.61 Million TWD , down -39.81% from previous year.
Sunder Biomedical Tech. Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 69.33 Million TWD , up 18.87% from previous quarter.
Sunder Biomedical Tech. Co., Ltd. reported an annual EBITDA of 127.48 Million TWD in 2022, down -34.24% from previous year.
Sunder Biomedical Tech. Co., Ltd. reported an annual EBITDA of 193.39 Million TWD in 2021, up 24.66% from previous year.
Sunder Biomedical Tech. Co., Ltd. reported a quarterly EBITDA of 18.28 Million TWD for 2023 Q2, down -56.02% from previous quarter.
Sunder Biomedical Tech. Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, down -39.81% from previous quarter.

Annual EBITDA Chart of Sunder Biomedical Tech. Co., Ltd. (2023 - 2019)

Name	EBITDA	EBITDA Difference
St.Shine Optical Co.,Ltd.	1.01 Billion TWD	92.422%
Bioteque Corporation	736.13 Million TWD	89.593%
Chi Sheng Pharma & Biotech Co., Ltd	117.55 Million TWD	34.826%
BenQ Medical Technology Corporation	532.15 Million TWD	85.603%
Pacific Hospital Supply Co., Ltd	673.8 Million TWD	88.63%
Unicon Optical Co., Ltd.	377.24 Million TWD	79.692%
Formosa Optical Technology Co.,Ltd.	1.04 Billion TWD	92.672%
Medeon Biodesign, Inc.	-1.14 Billion TWD	106.709%
Concord Medical Co., Ltd.	137.47 Million TWD	44.271%
Crystalvue Medical Corporation	149.73 Million TWD	48.833%
Perfect Medical Industry Co., Ltd.	115.48 Million TWD	33.657%
ICARES Medicus, Inc.	165.54 Million TWD	53.72%
Lagis Enterprise Co., Ltd.	112.36 Million TWD	31.817%
Amed Co., Ltd.	157.32 Million TWD	51.303%